Christine Mann of the Dent Neurologic Institute and Charles Lynch of Oncology Copayment Solutions discuss the differences among product acquisitions through buy-and-bill, alternative injection or infusion centers, and specialty pharmacy.
Christine Mann of the Dent Neurologic Institute and Charles Lynch of Oncology Copayment Solutions offer insights based on their experience integrating buy-and-bill into a medical practice.
Christine Mann of the Dent Neurologic Institute and Charles Lynch of Oncology Copayment Solutions discuss what practices should consider from a financial perspective when they care considering buy-and- bill for their practice.
Bobbi Buell of OnPoint Oncology and Susie Fleecs, the administrator of a large ophthalmology practice, discuss their experiences managing inventory, product administration policies and procedures, and other logistical considerations for practices considering buy-and-bill.
Bobbi Buell of OnPoint Oncology and Susie Fleecs, the administrator of a large ophthalmology practice, discuss the impact that the medical benefit designation has on patients and practices as it relates to acquisition through buy-and-bill.
Bobbi Buell of OnPoint Oncology and Susie Fleecs, the administrator of a large ophthalmology practice, discuss important components of the coding and reimbursement process, a key part of the buy-and-bill acquisition method.
Read a summary of findings from the Acquisition Insights series, where 4 industry-leading experts discuss key considerations for practices who want to implement buy-and-bill.